Reducing survey burden

Feasibility and validity of PROMIS measures in multiple sclerosis

Angela Senders, Douglas Hanes, Dennis Bourdette, Ruth Whitham, Lynne Shinto

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

Background: Patient-reported outcomes are important for clinical research and care, yet administering and scoringthe questionnaires requires considerable effort and time. The Patient Reported Outcomes Measurement InformationSystem (PROMIS) could considerably reduce administrative obstacles and lessen survey burden for participants.Objective: Assess the feasibility and validity of PROMIS, compared to commonly-used legacy measures for multiplesclerosis (MS).Methods: In this cross-sectional survey, 133 participants with confirmed MS completed legacy surveys and PROMISComputerized Adaptive Tests (CATs) for depression, anxiety, pain, fatigue and physical function. We conducted a multitrait,multi-method analysis and verified results with confirmatory factor analysis.Results: The correlations between PROMIS and the corresponding legacy measures were large (0.67 to 0.87). Themulti-trait, multi-method criteria were generally well met, providing good evidence of the validity of PROMIS measures.PROMIS surveys asked fewer questions and required substantially less time to complete than the legacy scales.Conclusions: Our results provide evidence of the construct validity of PROMIS for use with MS patients. Severalaspects of the PROMIS CATs made them an important resource, including: (a) less time was required to complete them;(b) missing data was reduced; and (c) the automatic scoring referenced the general population. Our findings support theuse of PROMIS in MS research and may have broader implications for clinical care, as well.

Original languageEnglish (US)
Pages (from-to)1102-1111
Number of pages10
JournalMultiple Sclerosis
Volume20
Issue number8
DOIs
StatePublished - 2014

Fingerprint

Multiple Sclerosis
Patient Reported Outcome Measures
Surveys and Questionnaires
Research
Statistical Factor Analysis
Fatigue
Anxiety
Cross-Sectional Studies
Depression
Pain
Population

Keywords

  • Computerized Adaptive Test
  • multiple sclerosis
  • outcome measurement
  • PROMIS
  • self-reporting
  • survey design
  • validation

ASJC Scopus subject areas

  • Clinical Neurology
  • Neurology

Cite this

Reducing survey burden : Feasibility and validity of PROMIS measures in multiple sclerosis. / Senders, Angela; Hanes, Douglas; Bourdette, Dennis; Whitham, Ruth; Shinto, Lynne.

In: Multiple Sclerosis, Vol. 20, No. 8, 2014, p. 1102-1111.

Research output: Contribution to journalArticle

@article{5ae9faaad5e14e32a1f8acf0789852f4,
title = "Reducing survey burden: Feasibility and validity of PROMIS measures in multiple sclerosis",
abstract = "Background: Patient-reported outcomes are important for clinical research and care, yet administering and scoringthe questionnaires requires considerable effort and time. The Patient Reported Outcomes Measurement InformationSystem (PROMIS) could considerably reduce administrative obstacles and lessen survey burden for participants.Objective: Assess the feasibility and validity of PROMIS, compared to commonly-used legacy measures for multiplesclerosis (MS).Methods: In this cross-sectional survey, 133 participants with confirmed MS completed legacy surveys and PROMISComputerized Adaptive Tests (CATs) for depression, anxiety, pain, fatigue and physical function. We conducted a multitrait,multi-method analysis and verified results with confirmatory factor analysis.Results: The correlations between PROMIS and the corresponding legacy measures were large (0.67 to 0.87). Themulti-trait, multi-method criteria were generally well met, providing good evidence of the validity of PROMIS measures.PROMIS surveys asked fewer questions and required substantially less time to complete than the legacy scales.Conclusions: Our results provide evidence of the construct validity of PROMIS for use with MS patients. Severalaspects of the PROMIS CATs made them an important resource, including: (a) less time was required to complete them;(b) missing data was reduced; and (c) the automatic scoring referenced the general population. Our findings support theuse of PROMIS in MS research and may have broader implications for clinical care, as well.",
keywords = "Computerized Adaptive Test, multiple sclerosis, outcome measurement, PROMIS, self-reporting, survey design, validation",
author = "Angela Senders and Douglas Hanes and Dennis Bourdette and Ruth Whitham and Lynne Shinto",
year = "2014",
doi = "10.1177/1352458513517279",
language = "English (US)",
volume = "20",
pages = "1102--1111",
journal = "Multiple Sclerosis",
issn = "1352-4585",
publisher = "SAGE Publications Ltd",
number = "8",

}

TY - JOUR

T1 - Reducing survey burden

T2 - Feasibility and validity of PROMIS measures in multiple sclerosis

AU - Senders, Angela

AU - Hanes, Douglas

AU - Bourdette, Dennis

AU - Whitham, Ruth

AU - Shinto, Lynne

PY - 2014

Y1 - 2014

N2 - Background: Patient-reported outcomes are important for clinical research and care, yet administering and scoringthe questionnaires requires considerable effort and time. The Patient Reported Outcomes Measurement InformationSystem (PROMIS) could considerably reduce administrative obstacles and lessen survey burden for participants.Objective: Assess the feasibility and validity of PROMIS, compared to commonly-used legacy measures for multiplesclerosis (MS).Methods: In this cross-sectional survey, 133 participants with confirmed MS completed legacy surveys and PROMISComputerized Adaptive Tests (CATs) for depression, anxiety, pain, fatigue and physical function. We conducted a multitrait,multi-method analysis and verified results with confirmatory factor analysis.Results: The correlations between PROMIS and the corresponding legacy measures were large (0.67 to 0.87). Themulti-trait, multi-method criteria were generally well met, providing good evidence of the validity of PROMIS measures.PROMIS surveys asked fewer questions and required substantially less time to complete than the legacy scales.Conclusions: Our results provide evidence of the construct validity of PROMIS for use with MS patients. Severalaspects of the PROMIS CATs made them an important resource, including: (a) less time was required to complete them;(b) missing data was reduced; and (c) the automatic scoring referenced the general population. Our findings support theuse of PROMIS in MS research and may have broader implications for clinical care, as well.

AB - Background: Patient-reported outcomes are important for clinical research and care, yet administering and scoringthe questionnaires requires considerable effort and time. The Patient Reported Outcomes Measurement InformationSystem (PROMIS) could considerably reduce administrative obstacles and lessen survey burden for participants.Objective: Assess the feasibility and validity of PROMIS, compared to commonly-used legacy measures for multiplesclerosis (MS).Methods: In this cross-sectional survey, 133 participants with confirmed MS completed legacy surveys and PROMISComputerized Adaptive Tests (CATs) for depression, anxiety, pain, fatigue and physical function. We conducted a multitrait,multi-method analysis and verified results with confirmatory factor analysis.Results: The correlations between PROMIS and the corresponding legacy measures were large (0.67 to 0.87). Themulti-trait, multi-method criteria were generally well met, providing good evidence of the validity of PROMIS measures.PROMIS surveys asked fewer questions and required substantially less time to complete than the legacy scales.Conclusions: Our results provide evidence of the construct validity of PROMIS for use with MS patients. Severalaspects of the PROMIS CATs made them an important resource, including: (a) less time was required to complete them;(b) missing data was reduced; and (c) the automatic scoring referenced the general population. Our findings support theuse of PROMIS in MS research and may have broader implications for clinical care, as well.

KW - Computerized Adaptive Test

KW - multiple sclerosis

KW - outcome measurement

KW - PROMIS

KW - self-reporting

KW - survey design

KW - validation

UR - http://www.scopus.com/inward/record.url?scp=84904816643&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84904816643&partnerID=8YFLogxK

U2 - 10.1177/1352458513517279

DO - 10.1177/1352458513517279

M3 - Article

VL - 20

SP - 1102

EP - 1111

JO - Multiple Sclerosis

JF - Multiple Sclerosis

SN - 1352-4585

IS - 8

ER -